These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34275910)

  • 21. Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Lundin KF; Edström M; Forsgren L
    Parkinsonism Relat Disord; 2017 May; 38():41-47. PubMed ID: 28242255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfactory dysfunction and parasympathetic dysautonomia in Parkinson's disease.
    Kang P; Kloke J; Jain S
    Clin Auton Res; 2012 Aug; 22(4):161-6. PubMed ID: 22314778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study.
    Vaswani PA; Morley JF; Jennings D; Siderowf A; Marek K;
    Parkinsonism Relat Disord; 2022 Nov; 104():15-20. PubMed ID: 36194902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognition and the course of prodromal Parkinson's disease.
    Weintraub D; Chahine LM; Hawkins KA; Siderowf A; Eberly S; Oakes D; Seibyl J; Stern MB; Marek K; Jennings D;
    Mov Disord; 2017 Nov; 32(11):1640-1645. PubMed ID: 29063713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease.
    Yoo HS; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee PH
    J Neurol; 2019 Jul; 266(7):1601-1610. PubMed ID: 31011798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.
    Morbelli S; Chiola S; Donegani MI; Arnaldi D; Pardini M; Mancini R; Lanfranchi F; D'amico F; Bauckneht M; Miceli A; Biassoni E; Orso B; Barisione E; Benedetti L; Gianmario S; Nobili F
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1939-1950. PubMed ID: 34984501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson's Disease: Longitudinal Data from the PPMI Study.
    Koros C; Simitsi AM; Papagiannakis N; Bougea A; Prentakis A; Papadimitriou D; Pachi I; Beratis I; Stanitsa E; Angelopoulou E; Antonelou R; Bregianni M; Lourentzos K; Papageorgiou SG; Bonakis A; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2023; 13(5):811-818. PubMed ID: 37424476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between four published definitions of hyposmia in Parkinson's disease.
    Kanavou S; Pitz V; Lawton MA; Malek N; Grosset KA; Morris HR; Ben-Shlomo Y; Grosset DG
    Brain Behav; 2021 Aug; 11(8):e2258. PubMed ID: 34190430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anosmia and Ageusia in Parkinson's Disease.
    Tarakad A; Jankovic J
    Int Rev Neurobiol; 2017; 133():541-556. PubMed ID: 28802932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prodromal Parkinson disease in patients with idiopathic hyposmia.
    Marrero-González P; Iranzo A; Bedoya D; Serradell M; Niñerola-Baizán A; Perissinotti A; Gaig C; Vilaseca I; Alobid I; Santamaría J; Mullol J
    J Neurol; 2020 Dec; 267(12):3673-3682. PubMed ID: 32676768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.
    Bang Y; Lim J; Choi HJ
    Arch Pharm Res; 2021 Jun; 44(6):588-604. PubMed ID: 34145553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.
    Pilotto A; Heinzel S; Suenkel U; Lerche S; Brockmann K; Roeben B; Schaeffer E; Wurster I; Yilmaz R; Liepelt-Scarfone I; von Thaler AK; Metzger FG; Eschweiler GW; Postuma RB; Maetzler W; Berg D
    Mov Disord; 2017 Jul; 32(7):1025-1034. PubMed ID: 28509336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinctive Olfactory Pattern in Parkinson's Disease and Non-Neurodegenerative Causes of Hyposmia.
    Crespo Cuevas AM; Ispierto L; Vilas D; Planas A; Planas A; Isern I; Sanchez J; De Haro J; Alvarez R
    Neurodegener Dis; 2018; 18(2-3):143-149. PubMed ID: 29940577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.
    Berendse HW; Roos DS; Raijmakers P; Doty RL
    J Neurol Sci; 2011 Nov; 310(1-2):21-4. PubMed ID: 21705022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subjects at risk of Parkinson's disease in health checkup examinees: cross-sectional analysis of baseline data of the NaT-PROBE study.
    Hattori M; Tsuboi T; Yokoi K; Tanaka Y; Sato M; Suzuki K; Arahata Y; Hori A; Kawashima M; Hirakawa A; Washimi Y; Watanabe H; Katsuno M
    J Neurol; 2020 May; 267(5):1516-1526. PubMed ID: 32030520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
    Shin JH; Lee JY; Kim YK; Shin SA; Kim H; Nam H; Jeon B
    Neurology; 2020 Dec; 95(23):e3081-e3092. PubMed ID: 32989104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal assessment of autonomic dysfunction in early Parkinson's disease.
    Stanković I; Petrović I; Pekmezović T; Marković V; Stojković T; Dragašević-Mišković N; Svetel M; Kostić V
    Parkinsonism Relat Disord; 2019 Sep; 66():74-79. PubMed ID: 31320275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.
    Liu R; Umbach DM; Tröster AI; Huang X; Chen H
    Parkinsonism Relat Disord; 2020 Mar; 72():23-30. PubMed ID: 32092703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyposmia and apathy in early, de novo Parkinson's disease: Lessons from structural brain connectivity.
    Martinez-Nunez AE; Soltanian-Zadeh H; Latack K; Ghazi N; Mahajan A
    J Neurol Sci; 2023 Sep; 452():120767. PubMed ID: 37619327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.